Initially, the benzothiazepine derivative JTV519 (K210) was shown to correct SR Ca2+ leak in dog samples with heart failure (Yano et al, 2003) and decreased human RyR2 activity in recombinant channels harboring missense mutations (Lehnart et al, 2004). This evidence concerns the gene RYR2 and heart failure.